Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous PRP Eye Drops for Ocular Surface Disease
NCT04608084Phase 4Unknown
- Sponsor
- University Health Network
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Countries
- 1
01
Overview
A Phase 4 trial of autologous platelet-rich plasma eye drops in ocular surface disease (OSD), dry eye syndrome (DED), sponsored by University Health Network. Status: unknown.
02
Drugs
autologous platelet-rich plasma eye drops
03
Conditions
ocular surface disease (OSD)dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04608084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04608084.